Proactive Investors - Run By Investors For Investors

Breakfast News - Mporium, Horizon Discovery, Cerillion and others

Breakfast News - Mporium,  Horizon Discovery, Cerillion and others

What’s cooking in the IPO kitchen?

AIM

Pelatro—provider of proprietary software solutions to enterprise-level customers for various aspects of precision marketing for use in B2C applications. Offer TBC, expected 19 December 2017

Fusion Antibodies—Belfast based contract research organisation providing services to biopharmaceutical and diagnostics companies that are involved in the development of antibodies for both therapeutic drug and diagnostic applications.  Offer TBA. Due Mid Dec.

Sirius Petroleum—RTO. Becoming an operating company in the Ororo Field in Nigeria. Raising £7.2m/ Mkt Cap £35.6m.  Due 19 Dec.

Bushveld Minerals  LON:BMN —RTO of Bushveld Vametco and therefore 78.8% of Strategic Minerals Corporation, the intermediate holding company that owns a 75 per cent. interest in the Vametco Vanadium Mine.

Range Resources— oil and gas company listed on the ASX plans to admit to AIM on 13 Dec with market cap of £17.4m. Also acquiring Range Resources Drilling Services Limited, an oil services business based in Trinidad & Tobago  with extensive drilling capabilities.

Eqtec—Company with access to a proprietary advanced gasification technology used in industrial size power plants to convert waste into synthetic gas to generate electricity.  Raising £1.6m. Mkt Cap £8.7m. Due 21 Dec.

Volex VLX.L—The global provider of cable assemblies is proposing to move from the main market to AIM on 19 January. £71m market cap. FYMar18E rev £241.5m and £7.19m PBT

Belluscura— Provider of premium medical devices at value prices to address part of the global unmet need for affordable, premium quality medical devices.  Raising £7.5m to £10m. Offer TBA. Due early Dec

Miriad Advertising—Global video advertising company incorporated in 2015 and is engaged in the development of native in-video advertising . 2016 rev £0.7m and £7.3m operating loss. Offer TBA. Expected 6 Dec.

OnTheMarket—Intention to float on AIM to raise c.£50m which will be used to fund the growth of the OnTheMarket.com portal, already the third biggest UK residential property portal provider. Expected valuation £200m to £250m.

Main Market Specialist Fund Segment

Sure Ventures –Raising  up to £50m at £1. Focus on FinTech, IoT and Augmented/Virtual Reality. Due 8 Dec.

Main Market Standard Listing

Shefa Yamin minerals company focused on the exploration for precious stones in Northern Israel. Net Proceeds will be used to advance the Company's mining project. Offer TBA.

Main Market Premium Listing

GEMS Education—report by Reuters that th private schools group is seeking a $4.5bn to $5bn London float in 2018. FYAug17 rev $926.2m and adjusted EBITDA $261.6m.

Greensphere Capital -$500m raise.  Aims to provide Shareholders with an attractive yield from a portfolio of sustainable infrastructure assets diversified by geographies and sectors and to realise long-term growth  capital value.  Due 20 Dec

Vivo Energy—The Africa-focused company, which operates around 1,800 Shell forecourts across 16 countries  reported by City A.M. to be preparing for a London float next year

Aberdeen Standard European Logistics Income—Investment Trust targeting £250m raise. Investing in a high quality portfolio of European logistics assets. Due 15 Dec.

Tri-Pillar Infrastructure— Investing a broad range of infrastructure assets located predominantly in continental Europe and North America. Seeking £200m raise at 100p.  Due 8 December.

Sabre Insurance Group—Private motor insurance underwriter, founded in 1982. Raising C.£206m to purchase outstanding preference shares.  Generated gross written premiums  in 2016. Due December. 220p to 240p. Mkt cap £550m to £600m.

Aviva Investors Secure Income REIT  - Targeting £200m raise. Will invest in a diversified portfolio of high quality, long-lease commercial real estate assets located within the UK and leased to predominantly investment grade tenants. Due 8 Dec.

 
  
 
  
 
 
Breakfast buffet

Dewhurst (LON:DWHT) 692.5p £22.92m

Record results for the supplier of products for the lift, rail and keypad industries  for the year to 30 September 2017. Group sales for the year increased 12.2% to £52.9m (2016: £47.2m) assisted by positive currency movements during the period. Operating profit before amortisation of acquired intangibles was £6.2m (2016: £5.5m) and profit before tax was £6.0m (2016: £5.1m) up 17.3%. “The weaker pound is benefitting our reported figures. Against this, UK demand is more fragile at the moment and projects are subject to delay and deferral.  Both these effects are at least partly caused by the uncertainty regarding the path leading to and beyond Brexit.  So any progress, or lack of it, in the Brexit negotiations could materially affect our future results.” We could see no forecasts.

Phoenix Global Mining  (LON:PGM) 4.25p £9.76m

The “US-focused copper and cobalt exploration and development company, is pleased to announce that it has expanded the land position of the Empire Copper Mine in Idaho, USA (the 'Empire Mine') with the addition of 33 unpatented mining claims in the Horseshoe Block immediately north of the existing property.“

The Empire Mine land position increases by 70% from 819 acres to a total land package of 1,383 contiguous acres. Recorded copper, lead, zinc, silver and gold production from the Horseshoe Block as recently as 1979 with reported grades of 3.8% copper and 12% zinc. The new claims extend the exploration area to the north of the existing AP open pit resources by approximately 1.2 kilometres

PCI-PAL (LON:PCIP) 51.5p £16.34m

The customer engagement specialist focused on secure payment solutions, announces that it has won a further major reseller contract and two new UK local Government contracts in November 2017, through its partnership with global cloud contact centre telephony provider, 8x8 Inc. The current financial year has started well with recurring revenues showing a 50% growth year-on-year, with 100% client retention. Overall revenues are also ahead for the year-to-date, including less non-recurring, one-off revenue, as the revenue model transitions to a complete software as a service (SaaS) license fee focus. Set up fees and professional service charges will increasingly diminish in materiality as the business grows. We could see no forecasts.

Amino Technologies (LON:AMO) 189p £137.25m

“The Cambridge-based provider of digital entertainment solutions for IPTV, Internet TV and in-home multimedia distribution, today provides the following trading update for the year ended 30 November 2017. The Group expects to report a full year performance that demonstrates continued customer traction for its IP / cloud video software solutions and devices, despite industry-wide memory cost headwinds. Gross profit and adjusted profit before tax are expected to be in line with market expectations, whilst revenue is expected to be similar to the previous financial year due to product mix. The Company's cash position at 30 November 2017 was £13.0m.” FYNov17E rev £80.53m and £10.97m PBT. C. 3.5% yield

Mporium Group (LON:MPM) 7.25p £38.76m

“The technology firm delivering event-driven marketing, is pleased to announce a significant commercial agreement for its technology-led digital agency, Fast Web Media (FWM). The seven-figure contract with a fully-owned subsidiary of a FTSE 100 company, represents the largest contract ever awarded to FWM in its 20-year history. The agreement involves the provision of technology and agency services over a 12 month period, across four key international markets. FWM is renowned for creating bespoke digital strategies that deliver measurable commercial improvements.”  At the core of FWM’s offer  is Mporium IMPACT which identifies and monetises micro-moments, resulting in improved performance for digital advertising campaigns, from brand advertising to direct response.  We could see no forecasts.

Satellite Solutions (LON:SAT) 7.16p £48.88m

The specialist in delivery of alternative super-fast broadband services, has signed a sales and marketing agreement  with the European broadband joint venture company established between Viasat, Inc. and Eutelsat Communications. SSW will invest to provide additional resources in each country in anticipation of a material increase in customer numbers and sales. SSW therefore envisages an investment during the first year, as the scheme gains traction and scales up, of approximately £1m of total additional overhead, which will be partially offset by income generated from new customers. SSW expects this project will enable it to breakeven within 18 months of launch and to be earnings accretive thereafter. FYNov17E rev £41.5m and £0.2m PBT.

Cerillion (LON:CER) 154.2p £45.5m

“The billing, charging and customer relationship management software solutions provider, is pleased to announce that it has signed a significant new contract with a European telecommunications provider, worth an initial £5.0m and a total of £8.4m over five years.   

The contract covers the supply and installation of Cerillion's Enterprise BSS/ OSS suite, as well as managed service operations and ongoing support and maintenance of the solution. The system is a comprehensive, functionally rich, and fully integrated billing, charging and customer management solution, suitable for fixed, mobile, broadband and TV services. Secured after a rigorous tender process, begun in the summer, the contract starts immediately, with implementation expected to complete in early 2019.” FYSep18E rev £17.4m and £3.2m PBT.

Ace Liberty & Stone*­(NEX:ALSP) 104.5p £41.9m

“The active property investment company, capitalising on commercial property investment opportunities across the UK, are delighted to announce the following property transaction.

The Company has completed the purchase of New Majestic Bingo Hall, Longlands Road, Middlesbrough at a price of £4.15m. The entire property is let to Gala Leisure Limited at an annual rent of £313,000.

The Company has issued 10,800 shares at £1 in settlement of an invoice from a supplier.”

DXS International (NEX:DXSP) 7.5p £2.5m

AGM Statement from the developer and supplier of clinical decision support solutions to the NHS. “Although budget cuts by the NHS affected our organic development during the 2016-2017 year the company still achieved modest growth. I am however pleased to report that some NHS restructuring is happening which we believe will have a positive effect on our future revenues.

Since the financial year end we have continued to invest in R&D and have now completed phase one of a new range of products and solutions. We are also extremely excited about a tender the company has won which is ideal for piloting these new products and solutions and kicks off in January  2018.”

Horizon Discovery Group (LON:HZD) 260p £387.2m

The specialist in gene editing and gene modulation technologies, and ERS Genomics Ltd., today announce the extension of their pre-existing non-exclusive, worldwide license agreement to significantly expand Horizon's license coverage for the use of the CRISPR gene editing technology. This will enable Horizon to use CRISPR in multiple new areas across its products and services, providing access to additional revenue streams in new and existing markets, and further reinforcing Horizon's leadership position in gene editing and cell biology.   “Through this expanded license, we are able to provide unencumbered access to the benefits of this cutting-edge technology for an increased range of high value products and services." FYDec17E rev £36.9m & £6.5m loss.

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use